Science Hub

Pathology

Welcome to Nordic Biosite's Life Science Blog. Here, we will provide commentary on current events and trends in biological sciences, interesting stories about important scientists, technical tips and suggestions, and much more. Read on and learn something new.
Showing 1-6 of 12

Nanoparticles and microparticles drug delivery to the liver

Liver disease is a significant health concern that affects millions of people worldwide. The liver plays a crucial role in metabolism, detoxification, and bile production, and liver disease can significantly impact liver function. Early diagnosis and treatment are essential for managing liver disease, and nanoparticles and microparticles offer promising therapeutic approaches for early-stage liver disease.

Could the solution to Alzheimer’s disease come from monoclonal antibodies?

The 21st of September is World Alzheimer’s Day. This is an event to raise awareness and challenge stigmas around Alzheimer’s disease (AD), which is the most common type of dementia today, affecting around 8 million people in Europe and 20 million worldwide. With an ever-growing elderly population, these numbers are only expected to increase in the coming decades, along with emotional and economic hardships for families as well as major healthcare efforts at high societal costs. 

PD-1: Expanding Beyond Cancer Research with ProSci

There has been significant interest in the role of programmed cell death protein 1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) in modulating immune responses. The emergence of PD-1-targeted therapies has revolutionized cancer treatment, leading to a better understanding of immune checkpoint mechanisms and their uses in various research fields. Expand beyond cancer research with ProSci!

Interview with a scientist: immune resistance in lung cancer

Article originally published on Atlas Antibodies’website  and written by

 

Non-small cell lung cancers (NSCLCs) are epithelial lung cancers that differ from small cell lung cancers (SCLCs) by cells morphology and histology. Almost 85%of lung cancers are NSCLCs. 

Examples of NSCLCs include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Still, several other types occur less frequently, and all varieties can occur in unusual histologic variants.  

Although NSCLCs are less aggressive and progress more slowly than SCLCs, they are often identified later, and by the time of diagnosis, they will have already spread beyond the lungs.  

Moreover, NSCLCs (in particular NSCLCs harboring KEAP1 mutations) are less sensitive and often resistant to chemotherapy, radiation, and immune checkpoint inhibitors immunotherapy compared with SCLCs. 

5 Recent Advancements in Lung Cancer Research

In this blog post, we will explore 5 recent advancements in lung cancer research that are transforming the landscape of diagnosis, treatment, and prevention. Lung cancer is a formidable adversary that has plagued millions of lives worldwide. It is the leading cause of cancer-related deaths, responsible for more fatalities than breast, colon, and prostate cancers combined. However, amidst this challenging landscape, remarkable progress is being made in the field of lung cancer research. Scientific breakthroughs, innovative treatment approaches, and improved understanding of the disease are providing a glimmer of hope for patients and their families.

Unlocking the Mysteries of Alzheimer’s and Schizophrenia with Monoclonal Antibodies in Neuroscience Research

Monoclonal Antibodies in Neuroscience Research: Applications in Alzheimer’s Disease and Schizophrenia in partnership with Atlas Antibodies.

Subscribe to our newsletter

Get the latest news within your area of research to your inbox.
Subscribe →